Telomere length predicts neutrophil recovery in the absence of G-CSF after autologous peripheral blood stem cell transplantation

被引:0
|
作者
L F Lincz
F E Scorgie
J A Sakoff
K A Fagan
S P Ackland
A Enno
机构
[1] Hunter Haematology Research Group,Medical Oncology Department
[2] Mater Misericordiae Hospital,undefined
[3] Mater Misericordiae Hospital,undefined
[4] Cytogenetics Unit,undefined
[5] Hunter Area Pathology Service,undefined
[6] Hunter Haematology Unit,undefined
[7] Hunter Area Pathology Service,undefined
来源
关键词
telomere; haemopoietic recovery; G-CSF; autologous peripheral blood stem cell transplantation;
D O I
暂无
中图分类号
学科分类号
摘要
Haemopoietic regeneration after autologous peripheral blood progenitor cell (PBPC) transplantation can be delayed in some patients despite adequate infusion of CD34+ cells. This suggests variability in the proliferation potential of the implanted cells, a capacity that may be predicted by their telomere length. To test this theory, telomere length was measured on stored apheresis samples from 36 patients aged 46.6±11.1 years, who had undergone successful autologous PBPC transplantation with a median of 5.6 × 106/kg (1.3 × 106–36.1 × 106/kg) CD34+ cells. The mean PBPC telomere length for the cohort was 9.4±2.3 kbp. For patients who did not receive G-CSF post transplantation (n=7), days to absolute neutrophil recovery (ANC), ⩾0.1, 0.5 and 1.0 × 109 cells/l, were significantly inversely correlated with telomere length of the infused PBPC (r=−0.88, −0.81, −0.77, respectively; P<0.05,). However, no correlation was found for patients who received G-CSF from day 1 post transplantation (n=20). These data suggest that for transplantation with sufficient CD34+ cells, neutrophil recovery is less efficient in patients receiving infusions of cells with short telomeres, but this deficiency can be corrected with adequate post transplantation administration of G-CSF.
引用
收藏
页码:439 / 445
页数:6
相关论文
共 50 条
  • [21] Biosimilar G-CSF (filgrastim) is also efficient for peripheral blood stem cell mobilisation and no cryopreserved autologous transplantation
    Yafour, N.
    Osmani, S.
    Talhi, S.
    Brahimi, M.
    Hebbar, A.
    Bekadja, S.
    Mehalli, S.
    Benmir, I.
    Arabi, A.
    Bouhass, R.
    Bekadja, M. A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S243 - S243
  • [22] Autologous stem cell transplantation (APSCT) with G-CSF primed peripheral blood in acute myelogenous leukemia (AML)
    Rio, B
    Boccaccio, C
    Belhocine, R
    Perrot, JY
    Zittoun, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 344 - 344
  • [23] Changes in immunological recovery in patients who received post-transplant G-CSF or GM-CSF after autologous peripheral blood stem cell transplantation (PBSCT)
    Arpaci, F
    Dogru, T
    Ozturk, B
    Komurcu, S
    Ozet, A
    Yilmaz, MI
    Beyzadeoglu, M
    Turan, A
    Sengul, A
    Yalcin, A
    HAEMATOLOGIA, 2002, 32 (03) : 253 - 264
  • [24] Delayed Administration of Filgrastim (G-CSF) Following Autologous Peripheral Blood Stem Cell Transplantation (APBSCT) in Pediatric Patients Does Not Change Time to Neutrophil Engraftment and Reduces Use of G-CSF
    Pai, Vinita
    Fernandez, Soledad A.
    Laudick, Melissa
    Rosselet, Robin
    Termuhlen, Amanda
    PEDIATRIC BLOOD & CANCER, 2010, 54 (05) : 728 - 733
  • [25] Use of G-CSF after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide
    Maisano, Valerio
    Devillier, Raynier
    Furst, Sabine
    Legrand, Faezeh
    Harbi, Samia
    Faucher, Catherine
    Chabannon, Christian
    Granata, Angela
    Weiller, Pierre Jean
    Blaise, Didier
    BLOOD, 2017, 130
  • [26] Peg-Filgrastim after autologous peripheral blood stem cell transplantation:: a matched-pair analysis and kinetics of G-CSF
    Piccirillo, N
    De Matteis, S
    Laurenti, L
    Chiusolo, P
    De Vita, S
    Sorà, F
    Putzulu, R
    Reddiconto, G
    Farina, G
    d'Onofrio, G
    Leone, G
    BONE MARROW TRANSPLANTATION, 2005, 35 : S102 - S102
  • [27] G-CSF after immunoselected CD34+autologous peripheral blood stem cell transplantation:: a novel and optimized schedule of administration
    Piccirillo, N
    Sica, S
    Sorá, F
    Laurenti, L
    Chiusolo, P
    Reddiconto, G
    La Barbera, EO
    Leone, G
    BONE MARROW TRANSPLANTATION, 2001, 27 : S161 - S161
  • [28] Early or delayed administration of G-CSF after peripheral blood stem cell transplantation in lymphoma patients
    Wylezol, I.
    Snarski, E.
    Borawska, A.
    Halaburda, K.
    Jedrzejczak, W.
    Walewski, J.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S184 - S184
  • [29] Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF
    Hill, Geoffrey R.
    Morris, Edward S.
    Fuery, Madonna
    Hutchins, Cheyl
    Butler, Jason
    Grigg, Andrew
    Roberts, Andrew
    Bradstock, Ken
    Szer, Jeffrey
    Kennedy, Glen
    Morton, James
    Durrant, Simon
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (06) : 603 - 607
  • [30] Delayed recovery of neutrophil counts after peripheral stem cell transplantation which improved with administration of a minimal dose of G-CSF: A case report
    Mineishi, S
    Saito, T
    Kanda, Y
    Tanosaki, R
    Tobinai, K
    Takaue, Y
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (01) : 43 - 45